Deaths Prompt Genentech To Pull Psoriasis Drug
Genentech said Wednesday that doctors should immediately stop prescribing the drug, and should contact patients currently taking it to assess alternative treatments. Genentech will stop selling the drug on June 8.
The company estimates that about 2,000 patients in the U.S. are currently taking Raptiva for chronic psoriasis.
“Our decision to remove Raptiva from the...
To view the full article, register now.